94 related articles for article (PubMed ID: 12136340)
1. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes.
Bassuny WM; Ihara K; Matsuura N; Ahmed S; Kohno H; Kuromaru R; Miyako K; Hara T
Immunogenetics; 2002 Jul; 54(4):282-5. PubMed ID: 12136340
[TBL] [Abstract][Full Text] [Related]
2. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
3. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese.
Takahashi K; Satoh J; Kojima Y; Negoro K; Hirai M; Hinokio Y; Kinouchi Y; Suzuki S; Matsuura N; Shimosegawa T; Oka Y
Tissue Antigens; 2004 Mar; 63(3):231-6. PubMed ID: 14989712
[TBL] [Abstract][Full Text] [Related]
4. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese.
Yamashita T; Hamaguchi K; Kusuda Y; Kimura A; Sakata T; Yoshimatsu H
Tissue Antigens; 2004 Mar; 63(3):223-30. PubMed ID: 14989711
[TBL] [Abstract][Full Text] [Related]
5. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population.
Ahmed S; Ihara K; Bassuny WM; Kuromaru R; Kohno H; Miyako K; Matsuura N; Iwata I; Nagafuchi S; Hara T
Genes Immun; 2002 Apr; 3(2):96-101. PubMed ID: 11960307
[TBL] [Abstract][Full Text] [Related]
6. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population.
McCormack RM; Maxwell AP; Carson D; Patterson CC; Bingham A; Savage DA
Genes Immun; 2001 Jun; 2(4):233-5. PubMed ID: 11477480
[TBL] [Abstract][Full Text] [Related]
7. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
Balic I; Angel B; Codner E; Carrasco E; Pérez-Bravo F
Hum Immunol; 2009 Feb; 70(2):116-20. PubMed ID: 19136037
[TBL] [Abstract][Full Text] [Related]
8. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children.
Jonson CO; Lernmark A; Ludvigsson J; Rutledge EA; Hinkkanen A; Faresjö M
Pediatr Diabetes; 2007 Aug; 8(4):185-92. PubMed ID: 17659059
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese.
Ma Y; Tang X; Chang W; Gao L; Li M; Yan W
Chin Med J (Engl); 2002 Aug; 115(8):1248-50. PubMed ID: 12515273
[TBL] [Abstract][Full Text] [Related]
10. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Ban Y; Taniyama M; Tozaki T; Yanagawa T; Yamada S; Maruyama T; Kasuga A; Tomita M; Ban Y
Autoimmunity; 2001; 34(1):39-43. PubMed ID: 11681491
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Agarwal K; Czaja AJ; Jones DE; Donaldson PT
Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
[TBL] [Abstract][Full Text] [Related]
12. [Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity].
Jin P; Xiang B; Lin J; Huang G; Zhou WD; Zheng C; Chao C; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1246-9. PubMed ID: 19595177
[TBL] [Abstract][Full Text] [Related]
13. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis.
Giscombe R; Wang X; Huang D; Lefvert AK
J Rheumatol; 2002 May; 29(5):950-3. PubMed ID: 12022356
[TBL] [Abstract][Full Text] [Related]
14. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus.
Lee YJ; Lo FS; Shu SG; Wang CH; Huang CY; Liu HF; Wu CC; Yang TY; Chang JG
J Pediatr Endocrinol Metab; 2001 Apr; 14(4):383-8. PubMed ID: 11327371
[TBL] [Abstract][Full Text] [Related]
15. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Diabetes Incidence in Sweden Study Group.
Lowe RM; Graham J; Sund G; Kockum I; Landin-Olsson M; Schaefer JB; Törn C; Lernmark A; Dahlquist G
Autoimmunity; 2000 Oct; 32(3):173-80. PubMed ID: 11092697
[TBL] [Abstract][Full Text] [Related]
16. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein.
Wang XB; Zhao X; Giscombe R; Lefvert AK
Genes Immun; 2002 Jun; 3(4):233-4. PubMed ID: 12058260
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians.
Mojtahedi Z; Omrani GR; Doroudchi M; Ghaderi A
Diabetes Res Clin Pract; 2005 May; 68(2):111-6. PubMed ID: 15860238
[TBL] [Abstract][Full Text] [Related]
18. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.
Bouqbis L; Izaabel H; Akhayat O; Pérez-Lezaun A; Calafell F; Bertranpetit J; Comas D
Genes Immun; 2003 Mar; 4(2):132-7. PubMed ID: 12618861
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis.
Kavvoura FK; Ioannidis JP
Am J Epidemiol; 2005 Jul; 162(1):3-16. PubMed ID: 15961581
[TBL] [Abstract][Full Text] [Related]
20. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block.
Anjos SM; Tessier MC; Polychronakos C
J Clin Endocrinol Metab; 2004 Dec; 89(12):6257-65. PubMed ID: 15579786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
